```html

Yeast Infection (Candidiasis) in the Urinary Tract

Overview

Candidiasis of the urinary tract, often simply called a urinary yeast infection, occurs when Candida species—most commonly Candida albicans—grow excessively in the bladder, urethra, or kidneys. Unlike the more familiar vaginal yeast infection, urinary candidiasis is less common but can be painful and may signal an underlying systemic problem.

Who it affects: Adults of any age can develop urinary candidiasis, but it is predominantly seen in women, older adults, and individuals with weakened immune systems. According to the CDC, Candida accounts for 15‑25 % of all urinary tract infections (UTIs) in hospitalized patients, and up to 40 % of UTIs in patients with indwelling catheters.

Prevalence: Community‑acquired urinary candidiasis is relatively rare, estimated at 1‑2 % of all UTIs in the general population, whereas hospital‑acquired cases rise sharply—particularly in intensive‑care settings. Women are about three times more likely to develop urinary candidiasis than men, reflecting differences in urinary anatomy and higher rates of vaginal colonization.

Symptoms

Symptoms can be subtle at first and may overlap with bacterial UTIs. Common manifestations include:

• Burning or stinging sensation during urination (dysuria): A sharp, uncomfortable feeling that often worsens toward the end of the stream.
• Frequent urge to urinate: May be accompanied by small amounts of urine (urinary urgency).
• Painful urination (hematuria is uncommon but possible): In severe cases, blood may appear in the urine.
• Cloudy, milky, or foul‑smelling urine: Yeast can produce a yeasty or “bread‑like” odor.
• Pelvic or lower abdominal pain: Often described as a dull ache or pressure.
• Genital itching or irritation: Particularly in women, the vulvar area may feel itchy or sore.
• Flank pain or kidney‑area discomfort: Suggests upper‑tract involvement (pyelonephritis) and requires urgent evaluation.
• Systemic signs (rare): Fever, chills, and malaise may occur if the infection spreads to the bloodstream (candidemia).

Because many of these signs mimic bacterial UTIs, laboratory testing is essential for an accurate diagnosis.

Causes and Risk Factors

Direct causes

Candida is a normal inhabitant of the gastrointestinal and genitourinary tracts. Overgrowth leading to infection can result from:

• Antibiotic use: Broad‑spectrum antibiotics disrupt normal bacterial flora, allowing yeast to proliferate.
• Urinary catheters: Prolonged catheterization provides a surface for biofilm formation.
• Impaired immunity: Diabetes, HIV/AIDS, chemotherapy, steroids, or organ transplantation reduce the body’s ability to keep Candida in check.
• Urinary obstruction: Kidney stones, enlarged prostate, or congenital anomalies cause urinary stasis.
• High‑sugar urine (glycosuria): Common in poorly controlled diabetes, providing a nutrient‑rich environment for yeast.
• Hormonal changes: Pregnancy or estrogen‑containing contraceptives can alter the vaginal microbiome, increasing the chance of urethral colonization.

Who is at higher risk?

• Women, especially those who wear tight, non‑breathable clothing.
• Elderly individuals, particularly those in long‑term care facilities.
• Patients with diabetes mellitus (type 1 or type 2).
• People who have recently taken antibiotics or corticosteroids.
• Individuals with an indwelling urinary catheter or recent urologic surgery.
• Immunocompromised patients (HIV, cancer, transplant recipients).

Diagnosis

Because symptoms overlap with bacterial UTIs, a systematic approach is required.

Medical history and physical exam

• Review of recent antibiotic or steroid use, catheter history, diabetes control, and sexual activity.
• Physical exam focuses on abdominal tenderness, costovertebral angle (CVA) pain, and genital inspection.

Laboratory tests

1. Urine analysis (UA): May show white blood cells, but no bacteria on Gram stain.
2. Urine culture: The gold standard. A growth of Candida ≥10³ CFU/mL (colony‑forming units) from a clean‑catch specimen is diagnostic. C. albicans accounts for ~70‑80 % of isolates; non‑albicans species (e.g., C. glabrata, C. tropicalis) are increasing.
3. Urine microscopy: Yeast buds or pseudohyphae visible under light microscopy.
4. Blood cultures: Reserved for patients with fever, signs of sepsis, or immunosuppression.
5. Imaging (ultrasound, CT): Used when upper‑tract involvement is suspected, or to rule out obstruction.

Special considerations

In patients with indwelling catheters, a “catheter tip culture” may be taken to differentiate colonization from true infection.

Treatment Options

Treatment aims to eradicate Candida, relieve symptoms, and prevent recurrence.

Antifungal medications

Drug	Typical Dose	Route	Duration
Fluconazole	200 mg PO loading dose, then 100–200 mg daily	Oral (also IV for severe cases)	7‑14 days; 14‑21 days for kidney involvement
Itraconazole	200 mg PO twice daily	Oral	7‑14 days
Amphotericin B (lipid formulation)	3‑5 mg/kg IV daily	IV	10‑14 days (reserved for resistant strains or severe infection)
Echinocandins (caspofungin, micafungin)	Caspofungin 50 mg IV daily	IV	10‑14 days (non‑albicans, fluconazole‑resistant)

For uncomplicated lower‑tract infections, a single oral dose of fluconazole (150 mg) is often sufficient, mirroring treatment of uncomplicated vaginal candidiasis.

Adjunctive measures

• Catheter removal or replacement: The most effective step in catheter‑associated cases.
• Hydration: Increasing fluid intake helps flush yeast from the urinary tract.
• Pain relief: Acetaminophen or NSAIDs as needed for discomfort.

When oral therapy fails

Consider the following:

• Switch to a different antifungal class (e.g., from fluconazole to an echinocandin) if resistance is suspected.
• Obtain susceptibility testing on the cultured isolate.
• Investigate for obstructive uropathy, stones, or anatomical abnormalities that may harbor yeast.

Living with Yeast Infection (Candidiasis) in the Urinary Tract

Daily management tips

• Stay well‑hydrated: Aim for at least 2‑3 L of water daily unless fluid‑restricted by another condition.
• Maintain good genital hygiene: Clean front‑to‑back after toileting; avoid scented soaps or douches.
• Wear breathable clothing: Choose cotton underwear and loose‑fitting pants to reduce moisture.
• Control blood sugar: For diabetics, keep HbA1c below 7 % (or as advised) to limit glycosuria.
• Limit unnecessary antibiotics: Discuss alternatives with your physician whenever possible.
• Probiotic support: Some evidence suggests Lactobacillus rhamnosus or reuteri may help restore normal flora; consult your clinician before starting.
• Follow-up urine cultures: Usually repeated 1‑2 weeks after treatment completion to confirm eradication, especially in high‑risk patients.

Impact on quality of life

Repeated episodes can cause anxiety about sexual activity or catheter use. Open communication with healthcare providers, and possibly a referral to a urologist or infectious‑disease specialist, can provide reassurance and tailored management plans.

Prevention

• Optimal diabetes management: Tight glycemic control reduces urinary glucose, a key growth factor for Candida.
• Catheter hygiene: Use aseptic technique during insertion; replace catheters only when medically necessary.
• Avoid prolonged antibiotic courses: When antibiotics are essential, consider concurrent probiotic use (evidence still emerging).
• Stay dry: Change wet clothing promptly; use moisture‑wicking powders (talc‑free) if needed.
• Regular medical review: Annual check‑ups for patients with recurrent UTIs or immune compromise.
• Vaccination and infection control: For hospitalized patients, adhere to hand‑washing protocols and catheter‑bundles endorsed by the CDC.

Complications

If left untreated, urinary candidiasis can progress to more serious conditions:

• Ascending infection – Pyelonephritis: Yeast spreads to the kidneys, causing fever, flank pain, and possible renal scarring.
• Urosepsis: Systemic spread leading to hypotension, organ dysfunction, and a life‑threatening emergency.
• Obstructive uropathy: Biofilm formation may block ureters or catheters, resulting in hydronephrosis.
• Chronic urinary symptoms: Persistent frequency, urgency, and pain that impair daily activities.
• Development of resistant Candida strains: Overuse of fluconazole can select for C. glabrata or C. krusei, which are less responsive to standard therapy.

When to Seek Emergency Care

---

Sources: Mayo Clinic, CDC, NIH National Institute of Allergy and Infectious Diseases, WHO Fungal Disease Guidelines, Cleveland Clinic, Clinical Infectious Diseases (2022), JAMA Network Open (2023).

```